DAP-kinase induces apoptosis by suppressing integrin activity and disrupting matrix survival signals by Wang, Won-Jing et al.
 

 
 The Rockefeller University Press, 0021-9525/2002/10/169/11 $5.00
The Journal of Cell Biology, Volume 159, Number 1, October 14, 2002 169–179
http://www.jcb.org/cgi/doi/10.1083/jcb.200204050
 
JCB
 
Article
 
169
 
DAP-kinase induces apoptosis by suppressing integrin 
activity and disrupting matrix survival signals
 
Won-Jing Wang,
 
1
 
 Jean-Cheng Kuo,
 
1
 
 Chung-Chen Yao,
 
2,3
 
 and Ruey-Hwa Chen
 
1
 
1
 
Institute of Molecular Medicine,
 
 
 
2
 
Department of Orthodontics, College of Medicine, and 
 
3
 
Department of Dentistry, 
National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan
 
eath-associated protein kinase (DAP-kinase) is a
 
calcium/calmodulin-dependent serine/threonine ki-
nase, and participates in various apoptosis systems.
However, its apoptosis-promoting mechanism is poorly
understood. Here, we demonstrate that DAP-kinase sup-
presses integrin-mediated cell adhesion and signal trans-
duction, whereas dominant-negative interference of this
kinase promotes adhesion. This effect of DAP-kinase is
neither a consequence of apoptosis nor a result of decreased
expression of integrins. Rather, DAP-kinase downregulates
integrin activity through an inside-out mechanism. We
present evidence indicating that this adhesion-inhibitory
effect accounts for a major mechanism of the apoptosis
induced by DAP-kinase. First, in growth-arrested ﬁbroblasts,
D
 
DAP-kinase triggers apoptosis in cells plated on ﬁbronectin,
 
but does not affect the death of cells on poly-
 
L
 
-lysine. Second,
in epithelial cells, DAP-kinase induces apoptosis in the
anoikis-sensitive MCF10A cells, but not in the anoikis-
resistant BT474 cells. Most importantly, the apoptosis-
promoting effect of DAP-kinase is completely abolished by
enforced activation of integrin-mediated signaling pathways
from either integrin itself or its downstream effector, FAK.
Finally, we show that integrin or FAK activation blocks the
ability of DAP-kinase to upregulate p53. Our results indicate
that DAP-kinase exerts apoptotic effects by suppressing
integrin functions and integrin-mediated survival signals,
thereby activating a p53-dependent apoptotic pathway.
 
Introduction
 
Interactions of cells with the ECM regulate a variety of
cellular functions, such as growth, differentiation, migration,
and survival. Most normal cells require adhesion to correct
ECM for their survival, and inadequate or inappropriate
cell–matrix interaction often causes apoptosis, a phenomenon
known as anoikis (Frisch and Ruoslahti, 1997; Frisch and
Screaton, 2001). This apoptotic mechanism is crucial for
maintaining homeostasis, organization, and architecture of
epithelia of different organs, and resistance to anoikis results
in anchorage independence, a hallmark of malignant tumor
cells. This anchorage independence permits tumor cells that
display altered adhesion and migratory properties to sur-
vive and grow in inappropriate environments, thus promot-
ing metastasis (Frisch and Ruoslahti, 1997; Frisch and Screa-
ton, 2001).
Cell adhesion to ECM is primarily mediated by integrins.
In resting cells, integrins are present on the cell surface in an
inactive state. Activation of integrins can be mediated by
intracellular signals, termed inside-out signals, which induce
a high affinity and/or avidity state of integrin (Ginsberg et
al., 1992). The avidity state is regulated by integrin clustering,
which can be triggered by remodeling of the cytoskeletal
linkages or alterations of the receptor diffusion rate within
the cell membrane (Schoenwaelder and Burridge, 1999; van
Kooyk and Figdor, 2000). The affinity state of integrin,
however, is regulated by its conformational changes induced
by a number of signaling pathways or proteins that interact
with the cytoplasmic domains of integrins (Hughes and
Pfaff, 1998). Structural studies suggest that such inside-out
modulation of integrin affinity involves changes in the
spatial relationship of the cytoplasmic and/or transmem-
brane domains of the 
 
 
 
 and 
 
 
 
 subunits, thereby inducing a
long-range conformational change to affect the affinity of
the ligand binding domains (Vinogradova et al., 2000;
Takagi et al., 2001).
Besides connecting ECM with cytoskeleton, integrins are
also capable of inducing various signaling pathways upon
ligand binding. Engagement of several types of integrins has
been shown to play an important role in cell survival (Giancotti
and Ruoslahti, 1999). One initial step of the integrin-mediated
survival pathway involves the phosphorylation and activation
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of intracellular tyrosine kinases, such as FAK (Frisch and
Ruoslahti, 1997; Frisch and Screaton, 2001). Constitutive
activation of FAK protects epithelial cells from anoikis
(Frisch et al., 1996), whereas interference of FAK function
in primary fibroblasts and endothelial cells triggers apoptotic
death via a p53-dependent mechanism (Hungerford et al.,
1996; Ilic et al., 1998). Besides FAK, the ligation of a subset
of integrins also leads to the recruitment of integrin-linked
kinase and Shc. These three integrin-interacting molecules
mediate ECM-dependent survival by activating a number
of signaling pathways, including the phosphatidyl inositol
3-kinase/Akt, Raf/extracellular signal–regulated kinase, and
c-Jun NH
 
2
 
-terminal kinase pathways (for review see Frisch
and Screaton, 2001). Detachment of cells from the ECM
not only blocks these matrix-transduced survival pathways,
but also results in a significant alteration of cytoskeletal
structures. Evidence has emerged that such cytoskeletal
changes can regulate signaling molecules that affect anoikis
and/or induce the release of pro-apoptotic factors (Marti et
al., 1997; Puthalakath et al., 1999, 2001; Otto et al., 2000).
Death-associated protein kinase (DAP-kinase)* is an ac-
tin filament–associated pro-apoptotic protein (Cohen et al.,
1997). This calcium/calmodulin-dependent serine/threo-
nine kinase was identified by a functional cloning system
based on its involvement in the interferon-
 
 
 
–induced
apoptosis (Deiss et al., 1995). Subsequent studies revealed
that DAP-kinase functions as a positive mediator of apop-
tosis induced by a variety of stimuli, such as Fas, TNF-
 
 
 
,
TGF-
 
 
 
, ceramide, and oncogenes c-myc and E2F (Deiss et
al., 1995; Cohen et al., 1997; Inbal et al., 1997; Cohen et
al., 1999; Raveh et al., 2001; Jang et al., 2002; Pelled et al.,
2002; Yamamoto et al., 2002). Furthermore, overexpres-
sion of DAP-kinase induces apoptotic death and apoptotic
morphological changes, such as cell rounding and shrink-
age, in a number of cell systems (Cohen et al., 1997; Pelled
et al., 2002). In addition to its apoptosis-promoting activ-
ity, several lines of evidence indicate that DAP-kinase plays
an important role in tumor suppression. First, the expres-
sion of DAP-kinase is frequently lost in various tumor cell
lines and tissues (Raveh and Kimchi, 2001). Second, DAP-
kinase is capable of suppressing c-myc– and E2F-induced
oncogenic transformation (Raveh et al., 2001). Third, in
an experimental metastasis model, the expression level of
DAP-kinase is inversely correlated with the metastatic ac-
tivities of the tumors, and reintroducing DAP-kinase into
the highly metastatic tumors suppresses their ability to
form metastases in mice (Inbal et al., 1997), implying a role
of DAP-kinase in anoikis. However, despite such broad in-
volvement in various apoptotic systems, very little is known
about the mechanism by which DAP-kinase executes the
pro-apoptotic function. A recent study demonstrated that
DAP-kinase activates a p53-mediated apoptotic pathway
through a mechanism that requires p19
 
ARF
 
 (Raveh et al.,
2001). How cytoskeleton-localized DAP-kinase transduces
a pro-apoptotic signal to activate p19
 
ARF
 
, however, is cur-
rently unknown.
 
In this study, we investigated the pro-apoptotic mecha-
nism of DAP-kinase. We found DAP-kinase functions as a
negative regulator of integrin activity and cell adhesion. This
effect of DAP-kinase diminishes integrin-mediated survival
signals and plays a causative role in DAP-kinase–induced
apoptosis. Furthermore, we showed that the apoptotic in-
ducibility of DAP-kinase is completely lost in the anoikis-
resistant cells. Finally, integrin or FAK activation blocks
DAP-kinase–induced upregulation of p53. We conclude
that DAP-kinase exerts pro-apoptotic activity by suppress-
ing integrin activity and integrin-mediated survival signals,
thereby activating a p53-dependent apoptotic pathway.
 
Results
 
DAP-kinase induces apoptosis-independent 
morphological changes in 293T cells
 
To unravel the pro-apoptotic mechanism of DAP-kinase, in
particular, the mechanism by which DAP-kinase activates
p53, we wanted to determine the biochemical pathways and/
or biological effects induced by DAP-kinase in cells lacking
functional p53. We reasoned that, in such cells, the apop-
totic effect of DAP-kinase would be greatly attenuated, thus
allowing a longer period for the observation of DAP-kinase–
induced events that act upstream of p53. 293T cells carrying
inactive p53 were used for transfection with various DAP-
kinase expression vectors, and the morphologies of trans-
fected cells were determined 48 h after transfection. As
shown in Fig. 1 B, overexpression of a constitutively active
DAP-kinase mutant (
 
 
 
CaM), in which the catalytic activity
is no longer regulated by calcium/calmodulin (Cohen et al.,
1997), led to a dramatic morphological change, as evident by
 
 
 
30% of the transfected cells showing a round cell shape.
This phenotype was also observed in cells overexpressing the
wild-type DAP-kinase, albeit with a slightly lower frequency.
In cells transfected with a kinase-defective mutant of DAP-
kinase (K42A) or the vector backbone, however, no signifi-
cant cell rounding could be detected. Note that all three
DAP-kinase proteins were expressed at comparable levels
in 293T cells (Fig. 1 A). Despite the observation that the
cell rounding phenotype seemingly resembles apoptosis-like
morphological changes, no other apoptotic morphological
characteristics were detected, including membrane blebbing,
apoptotic body formation (Fig. 1 B), and nuclear condensa-
tion/fragmentation (unpublished data). Furthermore, cells
overexpressing DAP-kinase or 
 
 
 
CaM did not display DNA
fragmentation (Fig. 1, C and D), were stained negatively by
annexin V (Fig. 1 E), and showed normal mitochondrial lo-
calization of cytochrome c at 48 h after transfection (unpub-
lished data). This insensitivity of 293T cells to DAP-kinase–
induced apoptosis is most likely due to the inactivation of
p53 by SV40 T-Ag. Altogether, these results indicate that
DAP-kinase triggers morphological changes in 293T cells
and that this effect is not a consequence of apoptosis.
 
DAP-kinase suppresses integrin-mediated 
cell adhesion and signal transduction
 
Next, we investigated the molecular basis of DAP-kinase–
induced cell rounding. We first tested whether interference
 
*Abbreviations used in this paper: DAP-kinase, death-associated protein
kinase; MLC, regulatory light chain of myosin II; poly-HEMA, polyhy-
droxyethylmethacrylate. 
DAP-kinase induces apoptosis by inhibiting adhesion |
 
 Wang et al. 171
 
of cell–matrix interaction could account for this phenotype.
Indeed, 293T cells overexpressing DAP-kinase displayed a
decreased adherence to fibronectin, compared with cells
transfected with the vector backbone (Fig. 2 A). Further-
more, expression of the active 
 
 
 
CaM mutant caused a
greater reduction in the adhesive capability. This impaired
adhesion was not reversed by pretreatment of cells with
a broad-spectrum caspase inhibitor, zVAD-FMK, further
demonstrating that this effect is not due to DAP-kinase–
induced apoptosis. Because 293T cells expressed a detectable
amount of endogenous DAP-kinase (Fig. 1 A), a dominant-
Figure 1. DAP-kinase induces apoptosis-independent morphological 
changes in 293T cells. (A) 293T cells were transiently transfected 
with expression vectors for various DAP-kinase proteins or the 
vector backbone. The transfection efficiency was 90%. Expression 
of the corresponding proteins was determined by Western blot 
analysis. (B) Morphologies of the 293T transfectants. 2 d after trans-
fection, cell morphology was examined by phase-contrast microscopy 
and the percentage of cells with round morphology is indicated as 
mean   SD. Bar, 10  M. (C, D, and E) Apoptotic analyses of the 
293T transfectants. 2 d after transfection, cells as described in A 
were harvested and analyzed for their sub-G1 DNA content by flow 
cytometry analysis (C), DNA fragmentation by cell death detection 
ELISA (D), and binding to annexin V (E). As a control, 293T cells 
were irradiated with UV at 0.04 J/cm
2 followed by 24 h of incubation, 
and then subjected to the same analyses.
Figure 2. DAP-kinase inhibits integrin-mediated cell adhesion and 
ECM signal transduction. (A and B) 293T cells were transfected with 
various expression vectors as in Fig. 1. Immediately after transfection, 
cells were incubated with or without 50  M of zVAD-FMK through-
out the culture and assay periods. 2 days after transfection, cells 
were replated on fibronectin (A) or laminin (B) and allowed to 
adhere for 40 or 25 min as indicated. The percentage of adhesion 
was calculated as described in the Materials and methods. Data 
from three separate experiments are presented as mean   SD. (C) 
Cells as in A were assayed for their attachment to poly-L-lysine. 
Adhesion assays were performed as in A. (D) Effect of DAP-kinase 
on tyrosine phosphorylation of FAK and paxillin. 293T transfectants 
as described in A were plated on fibronectin for 1 h. Cells in 
suspension and attached were combined and then lysed. FAK 
or paxillin tyrosine phosphorylation was detected by immuno-
precipitations with anti-FAK or antipaxillin antibody, as indicated, 
followed by Western blotting with antibody to phosphotyrosine. 
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negative mutant, K42A, was introduced to block the func-
tion of the endogenous protein. This dominant-negative in-
terference of DAP-kinase led to a significant acceleration of
cell adhesion to fibronectin, as 
 
 
 
80% of the transfectants
were already attached at 25 min after plating. To determine
whether the anti-adhesive function of DAP-kinase was re-
stricted to fibronectin, 293T transfectants were tested for
their attachment to laminin. The results obtained from cell
adhesion to laminin remarkably resembled those from cell
attachment to fibronectin (Fig. 2 B), suggesting DAP-kinase
as a general inhibitor of cell–ECM interactions. In contrast,
adhesion to poly-
 
L
 
-lysine, which does not engage integrins,
was not affected by DAP-kinase (Fig. 2 C). Thus, DAP-kinase
specifically inhibits integrin-mediated cell adhesion.
To investigate whether the anti-adhesive effect of DAP-
kinase is accompanied by a blockage of signals elicited by
ECM, we evaluated the tyrosine phosphorylation status of
FAK, a key mediator of ECM growth and survival signals
(Frisch et al., 1996; Hungerford et al., 1996; Ilic et al.,
1997). When 293T cells carrying only the control vector or
the K42A mutant were allowed to adhere to fibronectin for
1 h, a significant amount of tyrosine-phosphorylated FAK
was detected (Fig. 2 D). However, the level of phosphory-
lated FAK was markedly reduced in cells expressing either
DAP-kinase or the 
 
 
 
CaM mutant. Furthermore, tyrosine
phosphorylation of paxillin, a downstream target of FAK
(Turner, 2000), was similarly downregulated by expression
of DAP-kinase or 
 
 
 
CaM (Fig. 2 D). Together, our results
demonstrate that DAP-kinase inhibits cell adhesion to ECM,
thereby disrupting integrin-mediated signal transduction.
 
DAP-kinase suppresses integrin function through 
an inside-out mechanism
 
To gain insight into the possible mechanism of the anti-ad-
hesive role of DAP-kinase, we investigated whether this ef-
fect of DAP-kinase is due to a downregulation of integrin
expression or activity. 293T cells require 
 
 
 
5
 
 
 
1 and 
 
 
 
6
 
 
 
1
for their attachment to fibronectin and laminin, respectively
(Bodary and McLean, 1990; Fig. S1, available at http://
www.jcb.org/cgi/content/full/jcb.200204050/DC1). How-
ever, flow cytometry analysis revealed that overall cell surface
expressions of the 
 
 
 
5, 
 
 
 
6, and 
 
 
 
1 integrins were not signifi-
cantly altered by the expression of DAP-kinase, 
 
 
 
CaM, or
K42A (Fig. S1). Thus, DAP-kinase is likely to affect cell ad-
hesion by modulating integrin activities. Conformational
changes in integrins are suggested to underlie the modula-
tion of their affinity for ECM components (O’Toole et al.,
1994). If DAP-kinase did inhibit cell adhesion by convert-
ing integrins into an inactive conformation, treatment of
cells with the integrin-activating antibody, which locks inte-
grins in an active conformation, should be able to reverse
this inhibitory effect. Indeed, when 293T cells transfected
with DAP-kinase or 
 
 
 
CaM were plated on fibronectin in
the presence of TS2/16 (van de Wiel-van Kemenade et al.,
1992), an activating antibody to 
 
 
 
1 integrin, the anti-adhe-
sion effect of DAP-kinase or 
 
 
 
CaM was totally eliminated
(Fig. 3 A). Similarly, treatment of these 293T transfectants
with Mn
 
2
 
 
 
, which induces a conformational change of 
 
 
 
1
integrin in favor of the high-affinity state (Gailit and Ruo-
slahti, 1988), abrogated the ability of DAP-kinase to sup-
press cell attachment (Fig. 3 B). These results suggest that
the adhesion inhibition by DAP-kinase involves a mecha-
nism that converts integrin into an inactive conformation.
To further ascertain that DAP-kinase indeed affects the
activity of integrin, we used the monoclonal antibody B44,
which recognizes a specific epitope in 
 
 
 
1 integrin, an
epitope that is of very limited accessibility under normal
conditions and is expressed upon ligand occupancy. There-
fore, expression of the B44 epitope would be an indication
of the presence of an active state of 
 
 
 
1 integrin on the cell
surface (Ni et al., 1998). Notably, ectopic expression of
DAP-kinase or 
 
 
 
CaM significantly reduced the level of B44
binding, which was completely reversed by pretreatment
with Mn
 
2
 
 
 
 (Fig. 3 C). Similar results were observed with an-
other monoclonal antibody to activated 
 
 
 
1 integrin, i.e.,
the HUTS-21 antibody (Table S1, available at http://
Figure 3. DAP-kinase suppresses integrin activity. (A and B) 
Activation of  1 integrin abrogates the anti-adhesion effect of DAP-
kinase. 293T cells transfected with DAP-kinase,  CaM, or vector 
control were detached at 2 d after transfection. Cells were incubated 
with the TS2/16 anti– 1-activating antibody (A) or MnCl2 (B), and 
then assayed for their attachment to fibronectin. (C) Effect of DAP-
kinase on the expression of the active conformation of  1 integrin. 
293T transfectants were incubated with antibody B44 specific to the 
activated  1 integrin or buffer alone (control), followed by labeling 
with the FITC-conjugated secondary antibody. Alternatively, cells 
were preincubated with 2 mM MnCl2 for 20 min at 37 C (Mn), and 
then subjected to the same immunostaining. Fluorescence intensity 
was determined by FACS
® analysis, and results of a representative 
experiment are shown. Mean fluorescence intensity ( SD) calculated 
from three independent experiments is listed on the right (*, P   0.05; 
**, P   0.005 compared with the vector control without receiving Mn). 
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www.jcb.org/cgi/content/full/jcb.200204050/DC1). Alto-
gether, we conclude that DAP-kinase suppresses cell adhe-
sion by inside-out modulation of integrin activity.
 
The anti-adhesion function of DAP-kinase 
is not dependent on cell types
 
Next, we investigated whether regulation of cell adhesion
and integrin activity by DAP-kinase is restricted to 293T
cells, which display a relatively weak adhesive capability and
a highly transformed morphology. NIH3T3 mouse fibro-
blast was chosen for our study because of its low transform-
ing activity and well spread morphology. Furthermore,
NIH3T3 cells contain wild-type p53 and are able to un-
dergo apoptotic death by ectopic expression of DAP-kinase
(Raveh et al., 2001), thus allowing the extension of our anal-
ysis to cells sensitive to the apoptotic effect of DAP-kinase.
We generated NIH3T3 derivatives that express DAP-kinase,
 
 
 
CaM, or K42A by retrovirus-mediated gene transfer. Un-
der normal culture conditions, the 
 
 
 
CaM-expressing cells
started to die at 6–7 d after infection, and were virtually
eliminated by 9 d after infection (unpublished data). To rule
out the possibility that any adhesive change detected was a
consequence of apoptosis, we only used cells 4 d after infec-
tion for our analysis. By this time, the expression of wild-
type and mutant DAP-kinase proteins was readily detected
(Fig. 4 A), yet apoptosis had not occurred in these cell popu-
lations (Fig. 4 B). Notably, unlike what was observed in
293T cells, expression of DAP-kinase or 
 
 
 
CaM did not sig-
nificantly change the morphology of NIH3T3 cells (unpub-
lished data), presumably due to a higher affinity of NIH3T3
cells than 293T cells to the substratum. However, when
these NIH3T3 derivatives were replated onto fibronectin,
we found that expression of various forms of DAP-kinase af-
fected the adhesion of NIH3T3 cells in the same fashion as
they did in 293T cells (Fig. 4 C). Furthermore, the adhesion
inhibitory effect of DAP-kinase or 
 
 
 
CaM was reversed by
preincubation of cells with Mn
 
2
 
 
 
 (Fig. 4 D) or a mouse 
 
 
 
1–
activating antibody, 9EG7 (unpublished data), indicating
that DAP-kinase utilizes a similar inside-out mechanism to
downregulate integrin activity in NIH3T3 cells. Altogether,
our data support that the effect of DAP-kinase on anti-adhe-
sion and integrin inactivation is a global mechanism and is
not restricted to a small subset of cell types.
 
DAP-kinase promotes apoptosis by blocking ECM 
survival signals
 
Many types of cells undergo apoptotic death when they are
deprived of integrin-mediated ECM survival signals (Frisch
and Ruoslahti, 1997; Frisch and Screaton, 2001). The find-
ing that DAP-kinase downregulates cell adhesion and inte-
grin activity prompted us to investigate whether these effects
of DAP-kinase could account for its apoptosis inducibility.
We first used the NIH3T3 stable cell system described
above. Again, cells at 4 d after infection were plated onto
fibronectin or poly-
 
L
 
-lysine. To study the effect of ECM
signals independently of signals from other extracellular
sources, such as growth factors, these cells were incubated in
culture medium without serum. 12 h after plating, the apop-
totic index of each cell population was determined by ELISA
assays measuring the events of DNA fragmentation. As
shown in Fig. 5 A, when the four populations of cells were
plated on poly-
 
L
 
-lysine, they displayed similarly high levels
of apoptosis. However, in NIH3T3 cells carrying the con-
trol vector, plating onto fibronectin-coated dishes signifi-
cantly reduced apoptosis. This survival-promoting activity
of fibronectin was virtually eliminated in cells expressing
DAP-kinase or the 
 
 
 
CaM mutant. Conversely, the protec-
tion effect of fibronectin was slightly increased in the K42A-
expressing cells, compared with the control cells, most likely
due to a dominant-negative inhibition of endogenous DAP-
kinase by this mutant. When these four populations of cells
plated on fibronectin were incubated in serum-containing
medium, each of them showed a background level of apop-
tosis, with an apoptotic index below 0.1 (unpublished data).
This latter result is consistent with the observations from a
number of cell types (Ilic et al., 1998; Valentinis et al.,
Figure 4. DAP-kinase inhibits adhesion of NIH3T3 cells by inside-
out modulation of integrin activity. (A) NIH3T3 cells were infected 
with retroviruses carrying various DAP-kinase or the control virus, 
and expression of the corresponding DAP-kinase proteins was 
determined at 4 d after infection by Western blot analysis. (B) Cells 
as in A were assayed for their sub-G1 DNA content. As a control, 
NIH3T3 cells were irradiated with UV at 0.02 J/cm
2 followed by
24 h incubation. (C) Cells as described in A were assayed for their 
attachment to fibronectin. Cells were allowed to adhere for 40 or 25 
min and adhesion assays were performed as described in Fig. 2. (D) 
Mn
2  treatment abrogates the inhibitory role of DAP-kinase in cell 
adhesion. Cells as in A were preincubated with or without MnCl2 
before assaying for their attachment to fibronectin. 
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1998), and highlights an overlapping role of ECM and
growth factors in promoting the survival of fibroblasts. In
addition to DNA fragmentation assays, we also performed
caspase 3 activity assays and obtained a similar result (Fig. 5
B). In conclusion, our data strongly suggest that interference
of ECM survival signals is a major mechanism of DAP-
kinase–induced apoptosis.
To further confirm the suppression of ECM survival sig-
nals as a mechanism of DAP-kinase–induced apoptosis, we
thought to test whether this death-promoting activity could
be blocked by enforced activation of ECM survival signals.
FAK is a key mediator of these signals and its activation res-
cues apoptosis caused by loss of ECM attachment (Frisch et
al., 1996). We thus investigated the effect of FAK activation
on DAP-kinase–induced apoptosis. NIH3T3 cells were
transfected with expression vectors for various DAP-kinase
proteins and/or CD2-FAK (Chan et al., 1994), a constitu-
tively active form of FAK. These transfected cells expressed
comparable levels of the corresponding DAP-kinase proteins
and the CD2-FAK (Fig. 5 C). As observed previously (Chan
et al., 1994), the CD2-FAK transfectants contained a
slightly higher level of FAK (Fig. 5 C), presumably due to
degradation of the fusion protein. 2 d after transfection, cells
were tested for their survival on fibronectin under serum-
starved conditions. In the absence of CD2-FAK, we found
that the apoptotic response of each of these DAP-kinase
transfectants was reminiscent of that seen in virally infected
cells (Fig. 5 D). Remarkably, when CD2-FAK was intro-
duced into these cells, it was capable of decreasing the apop-
totic index of each of these transfectants to a level that is
similar to what was observed with the K42A-expressing cells.
Furthermore, CD2-FAK could no longer reduce the apop-
totic level of K42A-expressing cells, indicating that the ob-
served anti-apoptotic effect of CD2-FAK is specific to DAP-
kinase. These data thus reinforce our conclusion that the
apoptotic effect of DAP-kinase is caused by its interference
with FAK-mediated ECM survival signals.
Next, we tested whether DAP-kinase–induced apoptosis
could be rescued by enforced activation of the integrin-
mediated signaling pathway from further upstream, that is, the
integrin itself. The activating antibody to mouse 
 
 
 
1 inte-
grin, 9EG7, not only was capable of blocking the anti-adhe-
sion effect of DAP-kinase (unpublished data), but also re-
stored FAK phosphorylation at tyrosine 397 in NIH3T3
cells expressing DAP-kinase or 
 
 
 
CaM and plated on fi-
bronectin (Fig. 6 A). Most importantly, this activating anti-
body (Fig. 6 B), but not a nonactivating antibody to mouse
 
 
 
1 integrin (Fig. 6 C), significantly reduced the apoptotic
inducibility of DAP-kinase or 
 
 
 
CaM in NIH3T3 cells. Al-
together, our studies clearly demonstrate the blockage of in-
tegrin-mediated survival signal as a major mechanism of
DAP-kinase–induced apoptosis.
 
DAP-kinase induces an anoikis-like apoptosis in 
epithelial cells, which is reversed by integrin activation
 
Having demonstrated the apoptotic mechanism of DAP-
kinase in fibroblasts, we next decided to broaden our analysis
using epithelial cells, which are well known to undergo de-
tachment-induced apoptosis, namely, anoikis. MCF10A hu-
man mammary epithelial cells were chosen for our study be-
cause of their high sensitivity to anoikis (Li et al., 1999). We
introduced various forms of DAP-kinase into MCF10A cells
by retrovirus-mediated gene transfer. Because prolonged cul-
Figure 5. DAP-kinase promotes apoptosis by blocking ECM 
survival signals. (A) DAP-kinase induces apoptosis in cells plated on 
matrix. NIH3T3 cells infected with various retroviruses at 4 d after 
infection were plated on fibronectin (FN) or poly-L-lysine (PLL) and 
cultured in the absence of serum for 12 h. Cells were harvested and 
apoptotic cells were determined by cell death detection ELISA. 
Data from triplicate experiments are presented as mean   SD. (B) 
NIH3T3 cells infected, plated, and cultured as in A were subjected 
to caspase 3 activity assays. (C) NIH3T3 cells were transiently 
transfected with the combinations of expression vectors as indicated. 
The transfection efficiency was  50%. The expression of various 
proteins was assayed by Western blot analyses with antibodies to 
DAP-kinase (top), FAK (middle), and tubulin (bottom). (D) CD2-FAK 
prevents DAP-kinase–induced apoptosis. NIH3T3 transfectants as in 
C were plated on fibronectin and cultured for 12 h under serum-
starved conditions. Apoptotic cells were assayed as described in A. 
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ture of the DAP-kinase or the 
 
 
 
CaM stable populations
caused apoptosis and eventually a complete loss of cells car-
rying the retroviral vectors, freshly infected cells were used
for analyzing their apoptosis levels under attached or suspen-
sion condition. By the time they were assayed for apoptosis,
each stable population still expressed the corresponding
DAP-kinase protein at a much higher level than the endoge-
nous level seen in cells carrying the control vector (Fig. 7 A).
The ability of these DAP-kinase– or 
 
 
 
CaM-expressing cells
to survive a few days in culture is presumably due to the
presence of a high concentration of EGF in the culture me-
dium (see Materials and methods), as EGF was demon-
strated to rescue anoikis in epithelial cells (Jost et al., 2001).
To assess the apoptotic effect of DAP-kinase, the four popu-
lations of cells were plated on dishes coated with either fi-
bronectin or the nonadhesive polyhydroxyethylmethacrylate
(poly-HEMA) and incubated in culture medium without
the addition of EGF. As shown in Fig. 7 B, the various ret-
rovirus-infected cells exhibited similar sensitivities to anoikis
when they were plated on poly-HEMA. However, when
they were seeded on fibronectin, cells expressing DAP-kinase
or 
 
 
 
CaM displayed not only a reduced adhesive capacity
(unpublished data), as what was observed from 293T and
NIH3T3 cell systems, but also an increased apoptotic level,
compared with cells carrying the control vector or the K42A
mutant (Fig. 7 B). Most importantly, this apoptosis-pro-
moting effect of DAP-kinase or 
 
 
 
CaM was completely
abrogated by incubating cells with the TS2/16 human
 
 
 
1–activating antibody, again demonstrating that DAP-
kinase–induced apoptosis can be prevented by an outside-in
activation of integrin function. Note that in cells carrying
the control vector or even the K42A mutant, TS2/16 was
still able to decrease the apoptotic index, presumably due to
its ability to further promote the adhesion of these cells (un-
published data). Nevertheless, this antibody did not protect
suspension-induced apoptosis in cells plated on poly-HEMA,
demonstrating that this antibody did not nonspecifically
inhibit apoptosis. Taken together, these data indicate that
DAP-kinase is able to trigger an anoikis-like process in epi-
thelial cells.
If DAP-kinase indeed induces anoikis in epithelial cells, it
should not evoke apoptosis in cells that are resistant to
anoikis. To test this hypothesis, we used the BT474 breast
carcinoma cell line, which was shown to be able to grow in
an anchorage-independent fashion (Xu et al., 2000). Simi-
larly, cells transfected with various DAP-kinase expression
Figure 6. Activation of integrin restores FAK tyrosine phosphory-
lation and protects cells from DAP-kinase–induced apoptosis. (A) 
NIH3T3 cells were transfected with various DAP-kinase expression 
constructs as indicated. 36 h after transfection, cells were cultured 
in serum-free medium for 8 h. The cells were then detached, incubated 
with or without 5  g/ml of 9EG7 in DME containing 1% BSA for 
30 min at 37 C, and plated onto fibronectin for 1 h. Cells were then 
harvested, lysed, and subjected to Western blot analysis with 
antibodies to FAK (bottom) and FAK phosphorylated at tyrosine 397 
(top). (B and C) NIH3T3 cells, transfected and cultured as in A, were 
incubated with the activating antibody 9EG7 (B) or the nonactivating 
antibody MB1.2 (C). Cells were then plated on fibronectin and 
cultured in serum-starved conditions in the presence of the corre-
sponding antibody for 7 h. Apoptotic cells were quantitated as 
described in Fig. 5.
Figure 7. DAP-kinase induces an anoikis-like apoptosis in epithelial 
cells. (A) MCF10A cells were infected with various DAP-kinase–
expressing retroviruses or the control virus. Infected cells were 
selected by puromycin and then harvested at 4 d after infection. 
Expression of various forms of DAP-kinase was detected by Western 
blot analysis. (B) Activation of  1 integrin rescues the survival of 
DAP-kinase– or  CaM-expressing cells. MCF10A derivatives as in 
A were plated on fibronectin or poly-HEMA and cultured in EGF-
deprived medium with or without TS2/16 for 24 h. Apoptotic cells 
were quantitated as described in Fig. 5. 
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constructs were tested for apoptosis by plating onto fi-
bronectin or poly-HEMA. In contrast to the findings with
MCF10A cells, DAP-kinase or  CaM did not induce apop-
tosis in either attached or detached BT474 cells (Fig. 8 B),
even though the various forms of DAP-kinase were ex-
pressed at high levels in these transfectants (Fig. 8 A). Alto-
gether, our data support the conclusion that DAP-kinase in-
duces an anoikis-like apoptosis in epithelial cells.
Activation of integrin or FAK blocks 
DAP-kinase–induced upregulation of p53
DAP-kinase was recently reported to link oncogenes myc
and E2F to a p53-mediated apoptotic checkpoint (Raveh et
al., 2001); thus activation of p53 represents one mechanism
by which DAP-kinase exerts its pro-apoptotic effect. To ad-
dress how DAP-kinase leads to p53 activation, we examined
whether this activation is a consequence of DAP-kinase–
induced anti-adhesion and whether enforced activation of
ECM survival signals could abolish this activation. We first
measured p53-dependent transcriptional activation in a re-
porter assay. Consistent with previous findings in mouse
embryonic fibroblasts (Raveh et al., 2001), transfection of
NIH3T3 cells with DAP-kinase or  CaM caused a signifi-
cant induction of transcription from a p53-responsible re-
porter, p53-TA-luc (Fig. 9, A and B). Importantly, this
DAP-kinase–induced reporter activity, but not the basal re-
porter activity, was almost completely abrogated by either
cotransfection of CD2-FAK (Fig. 9 A) or treatment with the
9EG7   1-activating antibody (Fig. 9 B), indicating that
suppression of cell adhesion accounts for a mechanism by
which DAP-kinase activates p53. Next, we determined
whether these alterations in p53 activity are correlated with
changes in the endogenous p53 protein level. Western blot
analysis revealed that DAP-kinase or  CaM caused an in-
Figure 8. DAP-kinase can no longer promote apoptosis in cells 
resistant to anoikis. (A) Expression of the various forms of DAP-
kinase in BT474 breast carcinoma cells. BT474 cells were transiently 
transfected with expression vectors for various DAP-kinase proteins 
or a control vector. The transfection efficiency was  60%. 2 d after 
transfection, cells were lysed and subjected to Western blot analyses 
with antibodies as indicated. (B) BT474 transfectants as in A were 
plated on poly-HEMA or fibronectin and cultured for 24 h under 
serum-free conditions. Apoptotic cells were assayed as described 
in Fig. 5.
Figure 9. Integrin or FAK activation blocks the 
induction of p53 by DAP-kinase. (A) NIH3T3 cells 
were cotransfected with p53-TA-luc and pRK5- gal, 
in the presence or absence of various DAP-kinase 
expression constructs and CD2-FAK. At 36 h after 
transfection, cells were plated on fibronectin, cul-
tured in serum-free medium for 12 h, and then lysed 
for measuring reporter activities. Values are
mean   SD of triplicate assays. (B) NIH3T3 cells 
were cotransfected with p53-TA-luc and pRK5- gal 
in the presence or absence of various DAP-kinase 
expression constructs. Cells were then serum 
starved, incubated with or without 9EG7, and plated 
on fibronectin as described in the Materials and 
methods. Reporter activities were determined as 
in A. (C) NIH3T3 cells transfected as indicated were 
cultured for 36 h in growth medium and then plated 
on fibronectin-coated dishes. Cells were cultured 
under serum-free conditions for 6 h and subjected 
to Western blot analysis with antibodies as indicated. 
(D) A model illustrating the mechanism by which 
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crease in the p53 protein level, and, again, this elevation of
p53 was abolished by CD2-FAK (Fig. 9 C). Thus, the
blockage of ECM survival signals by DAP-kinase is responsi-
ble for its induction of p53. In summary, we conclude that
DAP-kinase triggers apoptosis by suppression of integrin-
mediated cell adhesion, thereby activating a p53-dependent
apoptotic pathway.
Discussion
In this study, we demonstrate an inhibitory role of DAP-
kinase in integrin-mediated cell adhesion and ECM signal
transduction. This effect of DAP-kinase is unlikely to be re-
stricted to a small set of cell types or specific ECM compo-
nents, as it was observed in several cell systems and on both
fibronectin and laminin matrixes. Furthermore, this adhe-
sion-suppressive effect is not a consequence of DAP-kinase–
induced apoptosis and can be readily detected in 293T cells,
which are relatively insensitive to the pro-apoptotic activity
of DAP-kinase due to the inactivation of p53. Even in
NIH3T3 cells, which undergo apoptotic death by ectopic
expression of DAP-kinase, this effect of DAP-kinase occurs
before the onset of apoptosis. In accordance with this no-
tion, the anti-adhesive function of DAP-kinase is not af-
fected by pretreatment of cells with the broad-spectrum cas-
pase inhibitor. These findings lead to a hypothesis that
DAP-kinase–induced downregulation of cell adhesion at-
tenuates the survival signals transduced from ECM and
plays a causative role in the pro-apoptotic function of DAP-
kinase. Indeed, several lines of evidence are presented to
support this notion. First, in serum-deprived NIH3T3 fi-
broblasts, which rely on ECM as the source of survival sig-
nals, DAP-kinase exerts its apoptosis-promoting effect on
cells plated on fibronectin but not on those plated on poly-
L-lysine. Second, in epithelial cells, DAP-kinase efficiently
induces apoptosis when expressed in the anoikis-sensitive
MCF10A cells, but not in the anchorage-independent
BT474 cells. Finally, and most importantly, the apoptotic
inducibility of DAP-kinase is abolished by enforced activa-
tion of integrin-mediated ECM survival signals from either
integrin itself or its downstream effector, FAK. Thus, down-
regulation of cell adhesion, which leads to a suppression of
ECM survival signals, accounts for at least one mechanism
of DAP-kinase–induced apoptosis. In this regard, DAP-
kinase may be considered an anoikis inducer in anchorage-
dependent cell types.
Disruption of cell–ECM interactions in serum-deprived
endothelial cells and fibroblasts causes the activation of a
p53-mediated apoptotic pathway (Ilic et al., 1998). Cell at-
tachment to fibronectin suppresses this apoptosis through
the activation of FAK (Almeida et al., 2000). Interestingly,
DAP-kinase was reported to induce apoptosis via a p53-
dependent mechanism (Raveh et al., 2001). In this study,
we demonstrate that enforced activation of either integrin or
FAK blocks the ability of DAP-kinase to upregulate p53.
This finding indicates that induction of p53 by DAP-kinase
is primarily mediated by its adhesion inhibitory effect; thus
placing p53 downstream of integrin inactivation along the
apoptotic pathway of DAP-kinase. Previous study reveals
the involvement of cPLA2 and PKC  /  in the p53 activa-
tion in response to the deprivation of both growth factors
and matrix attachment (Ilic et al., 1998). Additional studies
are required to determine the involvement of these signaling
molecules in DAP-kinase–induced p53 activation.
We have examined the mechanism underlying the anti-
adhesive effect of DAP-kinase. We found that DAP-kinase
does not affect cell surface expression of the integrins that
are responsible for ECM attachment, but, rather, inhibits
the activities of these integrins by converting them into an
inactive conformation. How DAP-kinase transduces an in-
side-out signal to affect the conformation of integrins is cur-
rently unclear. Nevertheless, the requirement of DAP-kinase
catalytic activity for the anti-adhesion effect implies an in-
volvement of phosphorylating specific substrates for DAP-
kinase. In a separate study, we have identified an in vivo sub-
strate for DAP-kinase, i.e., the regulatory light chain of
myosin II (MLC). However, unlike other kinases that lead to
MLC phosphorylation, such as MLC-kinase and Rho-
kinase, DAP-kinase triggers the disruption, rather than as-
sembly, of focal adhesions in fibroblasts and this effect does
not lead to a concomitant loss of stress fibers (unpublished
data). We predict that such uncoupling of the stress fiber
and focal adhesion formation would lead to a perturbation
of the balance between contractile and adhesion forces,
which in turn triggers an anoikis-like event. Indeed, in this
study, we clearly demonstrate that DAP-kinase exerts its
pro-apoptotic activity by suppressing cell adhesion and dis-
rupting adhesion-dependent survival signals. Taking these
findings together, we propose a model that depicts the path-
way by which DAP-kinase induces apoptosis (Fig. 9 D).
It is noteworthy that the conclusion from this study does
not rule out the possible existence of other mechanisms by
which DAP-kinase promotes apoptosis. Indeed, prolonged
expression of DAP-kinase in certain cells induces membrane
blebbing (Inbal et al., 2002), a characteristic of apoptosis.
Accordingly, we found that when a human hepatoma cell
line, Hep3B, was transfected with a GFP-fused DAP-kinase
and maintained in the presence of drug for selection of the
transfectants, the GFP-expressing cells formed small colo-
nies and eventually died with extensive membrane blebbing
(unpublished data). Note that the Hep3B cells are p53 null
(Jang et al., 2002) and should be insensitive to the p53-
mediated, matrix detachment–induced apoptosis. In addi-
tion to membrane blebbing, DAP-kinase also triggers au-
tophagic (type II) cell death in cells lacking functional p53
(Inbal et al., 2002)
We show that DAP-kinase specifically blocks matrix sur-
vival pathways and does not significantly affect apoptosis in
cells without receiving ECM signals. In contrast, it was pre-
viously reported that loss of DAP-kinase expression protects
cells from matrix detachment–induced apoptosis (Inbal et
al., 1997). These seemingly contradictory results may be at-
tributed, at least in part, to the different assay systems used.
In the present study, the death-promoting effect of DAP-
kinase was assayed in cells deprived of other signals that play
a redundant role with ECM signals for cell survival. Under
such conditions, DAP-kinase rapidly triggers cell death.
However, in the previous study, the role of DAP-kinase in
detachment-induced apoptosis was determined by soft agar
colony forming assays (Inbal et al., 1997), which evaluate178 The Journal of Cell Biology | Volume 159, Number 1, 2002
the long-term growth and survival of cells in semisolid,
growth factor–containing culture conditions. Thus, the
finding that loss of DAP-kinase promotes colony formation
in soft agar suggests that DAP-kinase expression is detrimen-
tal to the long-term growth and survival of cells.
DAP-kinase is the prototype of a family of several related
kinases, i.e., the DAP-kinase family (Cohen and Kimchi,
2001). Although the homology of their sequences is re-
stricted only to the kinase domains, each of these family
members was reported to exert an apoptosis-promoting ac-
tivity (Kawai et al., 1998; Sanjo et al., 1998; Inbal et al.,
2000). The present unraveling of the pro-apoptotic mecha-
nism of DAP-kinase has an impact on our understanding of
the functional basis of other family members. Interestingly,
most of these proteins are capable of inducing cell rounding
and detachment when overexpressed in certain cell systems
(Kawai et al., 1998; Sanjo et al., 1998; Inbal et al., 2000).
We thus propose that suppression of cell adhesion and block-
age of ECM survival signals might be a common mechanism
of apoptosis induced by the DAP-kinase family proteins. Ad-
ditional studies are required for testing this hypothesis.
Materials and methods
Plasmids
The expression vectors pRK5-DAPK and pRK5-DAPK42A were described
previously (Jang et al., 2002). The cDNA for DAPK CaM (Cohen et al.,
1997) was constructed by the Quick-Change site-directed mutagenesis kit
(Strategene) and then cloned to pRK5. The cDNAs for DAPK, DAPK42A,
and DAPK CaM were cloned to pBabepuro3 to generate retroviral vec-
tors. The expression vector for CD2-FAK (Chan et al., 1994) was a gift from
Gena Whitney (Bristol-Myers Squibb Pharmaceutical Research Institute,
Seattle, WA).
Cell culture, transformation, and retroviral infection
293T and NIH3T3 cells were cultured in DME containing 10% FCS.
BT474 cells were cultured in DME/F12 medium containing 5% FCS.
MCF10A cells were grown in DME/F12 medium supplemented with 5%
horse serum, 5  g/ml of insulin, 0.01  g/ml of EGF, 0.1  g/ml of cholera
toxin, and 0.5  g/ml of hydrocortisone. Transfection was performed by the
calcium phosphate method. Generation of recombinant retrovirus and in-
fection of NIH3T3 cells were performed following procedures described
previously (Tsai et al., 2000). For infection of MCF10A cells, the viral stock
was supplemented with 2  g/ml of polybrene and incubated with cells for
18 h. 2 d after the beginning of the infection, cells were selected in culture
medium containing 1  g/ml of puromycin. 2 d after selection, the unin-
fected cells were virtually eliminated and the surviving cells were used for
various analyses.
Antibodies and reagents
The polyclonal antibody to DAP-kinase was described previously (Jang et
al., 2002). The hybridoma for TS2/16 was from American Type Culture
Collection and the antibody was purified by affinity chromatography using
HiTrap protein G column (Amersham Biosciences). The mouse  1 inte-
grin–activating antibody 9EG7, the antibody HUTS-21 for activated hu-
man  1, antibodies to human  5 integrin (Vc5) and  6 integrin (GoH3),
and p53 were from BD Biosciences. The human  1 integrin antibody
AIIB2 was a gift from Caroline Damsky (University of California, San Fran-
cisco, CA). The antibody B44 for the activated human  1 integrin and the
antibody MB1.2 for mouse  1 integrin were from Chemicon. Antibodies to
FAK, paxillin, and phosphotyrosine were from Transduction Laboratories,
whereas antibody to FAK phosphorylated at tyrosine 397 was from Bio-
source International.
Adhesion assays
Assays of cell adhesion on plates coated with 10 ng/ l of fibronectin, 30
ng/ l of laminin, 2 mg/ml of poly-L-lysine, or 1% BSA in PBS were per-
formed essentially as previously described (Mould et al., 1995). For exper-
iments with blocking or activating antibodies, cells were preincubated
with 5  g/ml of purified antibodies on ice for 30 min, and adhesion assays
were performed in the presence of antibodies. For experiments with Mn
2 ,
2 mM MnCl2 was added into cell suspension before the adhesion assays.
To estimate the reference value for 100% attachment, cells were seeded
on plates precoated with 20 ng/ l of fibronectin or 50 ng/ l of laminin and
incubated for 3–4 h at 37 C. After incubation, cells were fixed immediately
and  90–100% of input cells were recovered.
Flow cytometry analysis
To assess cell surface expression of specific integrins, cells were washed
with PBS and resuspended in blocking solution containing 5% dissociation
buffer (Invitrogen) and 2% goat serum in PBS. Cells were then incubated
with anti-integrin antibody for 1 h at 4 C, washed with blocking solution,
and labeled with FITC-conjugated secondary antibody for 30 min at 4 C.
Cells were then washed and analyzed on a Becton Dickinson FACScan
®
device. For detecting the activated  1 integrin, cells transfected with vari-
ous constructs were incubated in blocking solution with or without 2 mM
MnCl2 at 37 C for 30 min, followed by incubating with B44 or HUTS-21
antibody for 45 min at 4 C, and then labeled with secondary antibody as
described above.
Immunoprecipitations
Cells were lysed in buffer containing 50 mM Tris (pH 7.5), 150 mM NaCl,
1% NP-40, 1% sodium deoxycholate, 0.1% SDS, supplemented with 1
mM PMSF, 10  g/ml aprotinin, 10  g/ml leupeptin, 1 mM sodium vana-
date, 4 mM sodium pyrophosphate, and 20 mM NaF. Lysates containing
equal amount of proteins were subjected to immunoprecipitations as de-
scribed previously (Tsai et al., 2000).
Apoptosis and caspase activity assays
Cells transfected with various DAP-kinase expression constructs or infected
with recombinant retrovirus expressing DAP-kinase or its mutants were
seeded on plates precoated with 25 ng/ l of fibronectin, 0.1% poly-L-lysine,
or 0.5 ml of 12 mg/ml poly-HEMA and cultured for various time periods in
the presence or absence of integrin-activating antibody. For all apoptosis-
related assays, both detached and adherent cells were harvested and com-
bined. DNA fragmentation and caspase 3 activities were measured as de-
scribed previously (Jang et al., 2002). For determining the population of cells
with sub-G1 DNA content, cells were stained with propidium iodide and
then analyzed by flow cytometry. Annexin V staining was performed using
the Annexin V–FITC Apoptosis Detection Kit (Oncogene Research Products).
Reporter assays
To analyze transcriptional activity of p53, the p53-TA-luc reporter (CLON-
TECH Laboratories, Inc.) and the pRK5- gal plasmid were transfected into
NIH3T3 cells in the presence or absence of various DAP-kinase expression
constructs. Cells were detached at 36 h after transfection, replated onto
dishes coated with fibronectin, and cultured under serum-starved condi-
tions for 12 h. For experiments using the 9EG7 antibody, cells were fed
with serum-free medium at 36 h after transfection. 8 h later, cells were de-
tached and preincubated with 5  g/ml of 9EG7 in DME containing 1%
BSA at 37 C for 30 min. Cells were then plated on fibronectin and cultured
for another 4 h. In all cases, both attached and detached cells were har-
vested and combined. Luciferase and  -galactosidase activities were quan-
titated as previously described (Jang et al., 2002).
Online supplemental material
Table S1 and Fig. S1 are available online at http://www.jcb.org/cgi/content/
full/jcb.200204050/DC1. Table S1 shows the levels of HUTS-21 epitope
on cells transfected with various forms of DAP-kinase. Fig. S1 shows that
DAP-kinase does not affect cell surface expression of integrins.
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